2JNR

Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	0.75 mM VIR165, 0.75 mM FP1-23, 3%DMSO added	90% H2O/10% D2O	0	4.7	ambient	298
2	2D DQF-COSY	0.75 mM VIR165, 0.75 mM FP1-23, 3%DMSO added	90% H2O/10% D2O	0	4.7	ambient	298
3	2D 1H-1H TOCSY	0.75 mM VIR165, 0.75 mM FP1-23, 3%DMSO added	90% H2O/10% D2O	0	4.7	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	700
2	Bruker	DRX	500
3	Bruker	DPX	250

NMR Refinement
Method	Details	Software
molecular dynamics		SYBYL

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	1
Conformers Submitted Total Number	1
Representative Model	1 (minimized average structure)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	SYBYL		Tripos

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.